Journal:
:acta medica iranica
0
bita kalaghchi cancer research center, cancer institute, tehran university of medical sciences, tehran, iran. and department of radiation oncology, cancer institute, tehran university of medical sciences, tehran, iran.
ali kazemian department of radiation oncology, cancer institute, tehran university of medical sciences, tehran, iran.
farnaz amouzegar hashemi department of radiation oncology, cancer institute, tehran university of medical sciences, tehran, iran.
mehdi aghili department of radiation oncology, cancer institute, tehran university of medical sciences, tehran, iran.
farshid farhan department of radiation oncology, cancer institute, tehran university of medical sciences, tehran, iran.
peiman haddad department of radiation oncology, cancer institute, tehran university of medical sciences, tehran, iran.
to determine the addition of value of neoadjuvant, concurrent and adjuvant chemotherapy to radiation in the treatment of nasopharyngeal carcinoma with regard to the overall survival (os) and disease free survival (dfs) within a six year period in tehran cancer institute. files of all patients with nasopharyngeal carcinoma treated by radiotherapy with or without concurrent chemotherapy in a cura...